PharmaCorp Rx Inc. (TSXV:PCRX)

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Non-wholly Owned Pharmacies	6.24M	-	1.00
Wholly Owned Pharmacies	14.66M	-	-
Total	20.89M	-	1.00

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec 31, 2025	Dec 31, 2024
Canada	20.89M	5.79M
Canada Growth	260.57%	-
Total	20.89M	5.79M
Total Growth	260.57%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 9, 2026

Data Sources Report a data error